{
    "2020-03-09": [
        [
            {
                "time": "2023-03-15",
                "original_text": "Align Technology to Acquire exocad in Digital Dentistry Space",
                "features": {
                    "keywords": [
                        "Align",
                        "Technology",
                        "Acquire",
                        "exocad",
                        "Digital Dentistry"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Danaher (DHR) Poised to Gain From Buyouts Despite Cost Woes",
                "features": {
                    "keywords": [
                        "Danaher",
                        "DHR",
                        "Buyouts",
                        "Cost Woes"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "industrial",
                        "diversified"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "FDA commissioner: CDC coronavirus tests have been used for 1,583 patients",
                "features": {
                    "keywords": [
                        "FDA",
                        "commissioner",
                        "CDC",
                        "coronavirus",
                        "tests",
                        "patients"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}